Cognitive and Behavioral Effects of Lacosamide

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
Primary Objective: Null hypothesis: A 24-week trial of adjunctive Lacosamide does not produce a decline in cognitive, mood or quality of life measures. To determine the cognitive and behavioral side effects of lacosamide in patients with partial epilepsy and follow them for a period of 24 weeks using a neuropsychological test battery drawing on tests commonly used and designed to maximize sensitivity to drug effects. Secondary Objectives: To determine if any significant changes in cognitive, mood or quality of life measures are dependent upon changes in seizure severity, neurotoxicity, adverse events, or Lacosamide dosage.
Epistemonikos ID: 9801486a790dfbfe09eba38ba01b422205d1b578
First added on: May 05, 2024